Literature DB >> 16493056

Molecular genetic analysis of the Idd4 locus implicates the IFN response in type 1 diabetes susceptibility in nonobese diabetic mice.

Evgueni A Ivakine1, Omid M Gulban, Steven M Mortin-Toth, Ellen Wankiewicz, Christopher Scott, David Spurrell, Angelo Canty, Jayne S Danska.   

Abstract

High-resolution mapping and identification of the genes responsible for type 1 diabetes (T1D) has proved difficult because of the multigenic etiology and low penetrance of the disease phenotype in linkage studies. Mouse congenic strains have been useful in refining Idd susceptibility loci in the NOD mouse model and providing a framework for identification of genes underlying complex autoimmune syndromes. Previously, we used NOD and a nonobese diabetes-resistant strain to map the susceptibility to T1D to the Idd4 locus on chromosome 11. Here, we report high-resolution mapping of this locus to 1.4 megabases. The NOD Idd4 locus was fully sequenced, permitting a detailed comparison with C57BL/6 and DBA/2J strains, the progenitors of T1D resistance alleles found in the nonobese diabetes-resistant strain. Gene expression arrays and quantitative real-time PCR were used to prioritize Idd4 candidate genes by comparing macrophages/dendritic cells from congenic strains where allelic variation was confined to the Idd4 interval. The differentially expressed genes either were mapped to Idd4 or were components of the IFN response pathway regulated in trans by Idd4. Reflecting central roles of Idd4 genes in Ag presentation, arachidonic acid metabolism and inflammation, phagocytosis, and lymphocyte trafficking, our combined analyses identified Alox15, Alox12e, Psmb6, Pld2, and Cxcl16 as excellent candidate genes for the effects of the Idd4 locus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16493056     DOI: 10.4049/jimmunol.176.5.2976

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

Review 1.  Natural killer cell memory.

Authors:  Silke Paust; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

Review 2.  Immune cell trafficking to the islets during type 1 diabetes.

Authors:  A M Sandor; J Jacobelli; R S Friedman
Journal:  Clin Exp Immunol       Date:  2019-08-30       Impact factor: 4.330

3.  γδ T cells are essential effectors of type 1 diabetes in the nonobese diabetic mouse model.

Authors:  Janet G M Markle; Steve Mortin-Toth; Andrea S L Wong; Liping Geng; Adrian Hayday; Jayne S Danska
Journal:  J Immunol       Date:  2013-04-26       Impact factor: 5.422

Review 4.  Immune checkpoint inhibitor diabetes mellitus: a novel form of autoimmune diabetes.

Authors:  Z Quandt; A Young; M Anderson
Journal:  Clin Exp Immunol       Date:  2020-02-28       Impact factor: 4.330

5.  Interferon gamma contributes to preimplantation embryonic development and to implantation site structure in NOD mice.

Authors:  A V C Seaward; S D Burke; B A Croy
Journal:  Hum Reprod       Date:  2010-09-02       Impact factor: 6.918

6.  Therapeutic Potential for Targeting the Suppressor of Cytokine Signalling-1 Pathway for the Treatment of SLE.

Authors:  B Sukka-Ganesh; J Larkin
Journal:  Scand J Immunol       Date:  2016-11       Impact factor: 3.487

7.  Genome-wide transcriptional analyses of islet-specific CD4+ T cells identify Idd9 genes controlling diabetogenic T cell function.

Authors:  Gregory J Berry; Christine Frielle; Thaiphi Luu; Anna C Salzberg; Daniel B Rainbow; Linda S Wicker; Hanspeter Waldner
Journal:  J Immunol       Date:  2015-02-11       Impact factor: 5.422

8.  Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression.

Authors:  Christian Hundhausen; Alena Roth; Elizabeth Whalen; Janice Chen; Anya Schneider; S Alice Long; Shan Wei; Rebecca Rawlings; MacKenzie Kinsman; Stephen P Evanko; Thomas N Wight; Carla J Greenbaum; Karen Cerosaletti; Jane H Buckner
Journal:  Sci Transl Med       Date:  2016-09-14       Impact factor: 17.956

9.  Nonobese diabetic (NOD) mice congenic for a targeted deletion of 12/15-lipoxygenase are protected from autoimmune diabetes.

Authors:  Marcia McDuffie; Nelly A Maybee; Susanna R Keller; Brian K Stevens; James C Garmey; Margaret A Morris; Elizabeth Kropf; Claudia Rival; Kaiwen Ma; Jeffrey D Carter; Sarah A Tersey; Craig S Nunemaker; Jerry L Nadler
Journal:  Diabetes       Date:  2007-10-16       Impact factor: 9.461

10.  Increased IFN-α-producing plasmacytoid dendritic cells (pDCs) in human Th1-mediated type 1 diabetes: pDCs augment Th1 responses through IFN-α production.

Authors:  Chang-Qing Xia; Ruihua Peng; Anna V Chernatynskaya; Lihui Yuan; Carolyn Carter; John Valentine; Eric Sobel; Mark A Atkinson; Michael J Clare-Salzler
Journal:  J Immunol       Date:  2014-06-27       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.